-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Insulet, Raises Price Target to $170

Benzinga·11/05/2026 22:07:55
Listen to the news
Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $170.